Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Eurofins Lancaster Laboratories, Inc
EIR
•Eurofins Lancaster Laboratories, Inc•October 21, 2021

Eurofins Lancaster Laboratories, Inc – FDA EIR, Oct 21, 2021

Record Details

An FDA surveillance inspection of Eurofins Lancaster Laboratories, Inc. was conducted from October 20-21, 2021, at their Lancaster, PA facility. Eurofins operates as a contract testing laboratory, providing comprehensive safety testing services for human cells, tissues, and cellular and tissue-based products (HCT/Ps), as well as biological drug products. Their services include microbiology, mycoplasma, genetic stability, viral safety, and biochemistry, applied to various materials such as human tissue (e.g., bone, cartilage, umbilical cord blood) and biopharmaceutical products. The inspection was carried out under regulatory frameworks including CP 7341.002 for HCT/Ps and CP 7345.848 for Biological Drug Products (CBER), focusing on the Quality, Laboratory Control, and Facility/Equipment Systems. The purpose was to confirm that testing, such as sterility, utilized identical USP methods and was performed within a controlled environment with calibrated equipment to ensure uniformity, consistency, reliability, and reproducibility. Crucially, the inspection concluded without any adverse findings; no objectionable conditions were noted, and consequently, a Form FDA 483 was not issued. This indicates that Eurofins Lancaster Laboratories, Inc. demonstrated compliance with applicable regulations, and no specific corrective actions were required from the company based on this report.

Company
Eurofins Lancaster Laboratories, Inc
Inspection date
October 21, 2021
Product type
Biologics
Office
Team Biologics
People
  • Earl Hess (other)
  • Koreene N. D" Agostino (company_representative)
  • Neal A. Salerno (recipient)
  • Burnell M. Henry (Investigator)
  • Anjan K. Mittal (company_representative)
View Company Profile

ID · 54ec3aa7-0ea2-469c-81e8-be7f1a979149

Violation Codes1
21 CFR 820.100

Full citation text and observation details available on the Dashboard.

Other documents for Eurofins Lancaster Laboratories, Inc
  • 483 - 2025-08-26August 26, 2025
  • EIR - 2019-10-17October 17, 2019
  • EIR - 2019-09-13September 13, 2019
  • EIR - 2017-09-28September 28, 2017
  • EIR - 2015-06-19June 19, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Eurofins Lancaster Laboratories, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.